These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33813919)

  • 1. Inadequate Measles, Mumps, Rubella, and Varicella Immunity Among Employees.
    Ezeji-Okoye S; Bilodeau BL; Madhusudhan DK; Pruett E; Thokala S; Bravata DM
    J Prim Care Community Health; 2021; 12():21501327211005902. PubMed ID: 33813919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save?
    Alp E; Cevahir F; Gökahmetoglu S; Demiraslan H; Doganay M
    J Infect Public Health; 2012 Apr; 5(2):127-32. PubMed ID: 22541258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Inadequate Immunity to Measles, Mumps, Rubella, and Varicella in MLB and NBA Athletes.
    Conway JJ; Toresdahl BG; Ling DI; Boniquit NT; Callahan LR; Kinderknecht JJ
    Sports Health; 2018; 10(5):406-411. PubMed ID: 29792776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.
    Nolan T; McIntyre P; Roberton D; Descamps D
    Vaccine; 2002 Dec; 21(3-4):281-9. PubMed ID: 12450703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
    Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMR and MMRV vaccines.
    Kowalzik F; Faber J; Knuf M
    Vaccine; 2018 Aug; 36(36):5402-5407. PubMed ID: 28757060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic screening and infectious disease consultation (IDC): Indicated in heart, lung, liver (HLL) solid organ transplants (SOT) for measles, mumps, rubella, and varicella.
    Seckin ZI; Brumble LM; Libertin CR
    Transpl Infect Dis; 2020 Feb; 22(1):e13202. PubMed ID: 31647159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
    Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
    Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants.
    Yerkovich ST; Rowe J; Richmond P; Suriyaarachchi D; Heaton T; Hollams E; Ladyman C; Serralha M; Sadowska A; Loh R; Wesselingh SL; Sly PD; Holt PG
    Vaccine; 2007 Feb; 25(10):1764-70. PubMed ID: 17224218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students.
    Socan M; Berginc N
    Wien Klin Wochenschr; 2008; 120(13-14):422-6. PubMed ID: 18726668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].
    Buxbaum S; Doerr HW; Allwinn R
    Dtsch Med Wochenschr; 2001 Nov; 126(46):1289-93. PubMed ID: 11709730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity against vaccine-preventable diseases among pregnant employees in Germany. A situation analysis before the introduction of the Measles Protection Act.
    Wolfschmidt-Fietkau A; Goertz RS; Goertzen S; Schmid K; Seidling M; Gherman E; Ochmann U; Drexler H
    Vaccine; 2024 Sep; 42(22):125996. PubMed ID: 38824086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?
    Llenas-García J; Rubio R; Hernando A; Arrazola P; Pulido F
    AIDS Care; 2013 Aug; 25(8):980-9. PubMed ID: 23244745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity against measles, mumps, rubella, and varicella among homeless individuals in Germany - A nationwide multi-center cross-sectional study.
    Graf W; Bertram F; Dost K; Brennecke A; Kowalski V; van Rüth V; Nörz DS; Wulff B; Ondruschka B; Püschel K; Pfefferle S; Lütgehetmann M; Heinrich F
    Front Public Health; 2024; 12():1375151. PubMed ID: 38784578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan.
    Hatakeyama S; Moriya K; Itoyama S; Nukui Y; Uchida M; Shintani Y; Morisawa Y; Kimura S
    Infect Control Hosp Epidemiol; 2004 Jul; 25(7):591-4. PubMed ID: 15301032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of medical and paramedical university students in Lebanon against measles, mumps, rubella and varicella: active measures are needed.
    Chamat S; Salameh P; Haddad N; Berry A; Chedid P; Bouharoun-Tayoun H
    J Infect Public Health; 2011 Aug; 4(3):125-34. PubMed ID: 21843858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
    Ödemiş Í; Köse Ş; Akbulut Í; Albayrak H
    Rev Esp Quimioter; 2019 Dec; 32(6):525-531. PubMed ID: 31642641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?
    Celikbas A; Ergonul O; Aksaray S; Tuygun N; Esener H; Tanir G; Eren S; Baykam N; Guvener E; Dokuzoguz B
    Am J Infect Control; 2006 Nov; 34(9):583-7. PubMed ID: 17097453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic screening and infectious diseases consultation in renal transplant candidates for measles, mumps, rubella and varicella.
    Seckin ZI; Libertin CR; Brumble LM
    Rom J Intern Med; 2021 May; 59(2):159-165. PubMed ID: 33565307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.